Itau Unibanco Holding S.A. Ironwood Pharmaceuticals Inc Transaction History

Itau Unibanco Holding S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$9.8 - $12.89 $29,762 - $39,146	-3,037 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$7.8 - $16.13 $1,482 - $3,064	190 Added 6.67%	3,037 $30,000
Q3 2018 Nov 13, 2018	SELL	$14.31 - $17.65 $1,173 - $1,447	-82 Reduced 2.8%	2,847 $53,000
Q2 2018 Aug 13, 2018	SELL	$11.83 - $16.2 $6,198 - $8,488	-524 Reduced 15.18%	2,929 $56,000
Q1 2018 May 14, 2018	BUY	$11.13 - $13.63 $26,266 - $32,166	2,360 Added 215.92%	3,453 $53,000
Q4 2017 Feb 09, 2018	SELL	$12.16 - $14.58 $8,718 - $10,453	-717 Reduced 39.61%	1,093 $16,000
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $21,846 - $26,914	1,810	1,810 $90,000

244

163M

11.5M

12.9K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $216M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.